- Home
- MBOT
as 04-18-2025 1:39pm EST
Microbot Medical Inc is a clinical-stage medical device company specializing in the research, design and development of next-generation robotic endoluminal surgery devices targeting the minimally invasive surgery space. It is focused on leveraging its robotic technologies to redefine surgical robotics while improving surgical outcomes for patients. Using its LIBERTY technological platform, the company is developing the first-ever fully disposable robot for various endovascular interventional procedures.
| Founded: | 2010 | Country: | United States |
| Employees: | N/A | City: | HINGHAM |
| Market Cap: | 79.2M | IPO Year: | N/A |
| Target Price: | $9.00 | AVG Volume (30 days): | 4.3M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.73 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.82 - $3.38 | Next Earning Date: | 05-14-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Microbot Medical Inc. News
MBOT Breaking Stock News: Dive into MBOT Ticker-Specific Updates for Smart Investing
MedTech Dive
9 days ago
Microbot posts pivotal surgical robot data; GE Healthcare hires Patient Care Solutions leader
MT Newswires
10 days ago
Sector Update: Health Care Stocks Gain Late Afternoon
MT Newswires
10 days ago
Microbot Medical Says Study Shows Endovascular Robotic System Feasible
GlobeNewswire
10 days ago
Microbot Medical® Shares Results from Its Pivotal Clinical Trial, Achieving 100% Robotic Navigation Success for the LIBERTY® Endovascular Robotic System
GlobeNewswire
18 days ago
REMINDER: Microbot Medical Announces Data from the Company’s ACCESS-PVI trial will be Presented via Podium Presentation at Society of Interventional Radiology Annual Meeting
GlobeNewswire
2 months ago
Microbot Medical Appoints Seasoned Endovascular Sales Executive to Lead its U.S. Sales Activities for LIBERTY® Endovascular Robotic System
GlobeNewswire
2 months ago
Robotic Telesurgery Data from Collaboration with Corewell Health™ Accepted for Presentation at the Cardiovascular Research Technologies Annual Meeting
GlobeNewswire
2 months ago
Microbot Medical Closes $13 Million Registered Direct Offering
Compare MBOT vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "MBOT Microbot Medical Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.